Cannabis Stocks ACB, TLRY Heat Up on European Expansion Hopes

  • Cantor Fitzgerald’s upgrade of Aurora Cannabis (ACB) stock today appears to be lifting the shares.
  • Cantor is bullish on the shares due to Aurora’s opportunity in Germany.
  • Aurora recently dismissed 12% of its workforce.
Cannabis stocks - Cannabis Stocks ACB, TLRY Heat Up on European Expansion Hopes

Source: Shutterstock

Cannabis stocks Aurora Cannabis (NASDAQ:ACB) and Tilray (NASDAQ:TLRY) are climbing today. A note from an analyst appears to have made investors more optimistic about the companies’ opportunities in Europe. In early trading, ACB stock was jumping 8.5% to $1.54, while TLY stock was rising 2.7% to $3.68.

Cannabis Stocks Rise on Cantor Fitzgerald’s Upgrade

Pablo Zuanic, an analyst at investment bank Cantor Fitzgerald, raised his rating today on ACB stock to “overweight” from “neutral.” The analyst contended that, if the U.S. Congress does not legalize cannabis, Germany will become the most important nation for cannabis sellers and marijuana stocks in the upcoming 12 to 18 months. Aurora and Tilray are the only publicly marijuana sellers with “a license to produce” cannabis in the European country, Zuanic wrote, according to Seeking Alpha.

The analyst is bullish on both ACB stock and TLRY stock. But he thinks that Aurora has a better outlook because of its more favorable valuation. Zuanic raised his price target on Aurora to 4.05 CAD from 3.90 CAD.

Other ACB Stock News

In separate news, Aurora Cannabis earlier this week confirmed that it was laying off 12% of its employees worldwide. The company has said that it is looking to become profitable on an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) basis in the first half of its fiscal 2023.

On May 12, Aurora Cannabis reported that its third-quarter revenue had slid to 50.4 million CAD, down from  55.2 million CAD during the same period a year earlier. On the bright side, the company’s EBITDA loss, excluding certain items, improved 41% year-over-year to 12.3 million CAD.

Our plan is working. The foundation of our confidence is our global medical cannabis business, which is both defensible and stable with margins that exceed 60%,” said Aurora CEO Miguel Marin on the company’s Q3 earnings call.

On the date of publication,  Larry Ramer did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Larry Ramer has conducted research and written articles on U.S. stocks for 15 years. He has been employed by The Fly and Israel’s largest business newspaper, Globes. Larry began writing columns for InvestorPlace in 2015. Among his highly successful, contrarian picks have been PLUG, XOM and solar stocks. You can reach him on Stocktwits at @larryramer.

Article printed from InvestorPlace Media,

©2023 InvestorPlace Media, LLC